Registration and Lunch
12:30 – 1:45 PM

Program and Q&A Session
1:45 – 4:30 PM

Supported by an educational grant from

This CME activity is jointly sponsored by

Dear Colleague:

Designed for hematologists and oncologists, this program offers scientific research and clinical developments in the application of T cell-targeting therapeutic management. You’ll hear new treatment advances that combine chemotherapy and microbiological advances in monoclonal antibodies (MAbs) while targeting CD2 to facilitate cancerous T cell depletion and healthy T cell preservation.

Derived from professional experience and clinical research, faculty will provide insight into the following areas:

• T cell depletion strategies
• Treatment after T cell transplantation
• Resistance of aggressive T cells
• Monoclonal antibody applications

To ensure a firm understanding of all course material presented, a faculty Q&A session will follow presentations. Seating for this course is limited, so register early to reserve your space.

I look forward to seeing you in Orlando.

Francine Foss, MD Course Director